The Centers for Disease Control and Prevention (CDC) on Monday alerted clinicians about the short supply of monoclonal antibody treatment for respiratory syncytial virus (RSV) in infants amid an uptick in demand.
RSV Treatment for Infants in Limited Supply: CDC
Written by Epoch Times